Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' DEPAULIS T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 20 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. HEWLETT WA; SCHMIDT DE; MASON NS; TRIVEDI BL; EBERT MH; DEPAULIS T
      SYNTHESIS AND 5-HT-3 RECEPTOR-BINDING OF 2-(HALO)ALKOXYL AND 3-(HALO)ALKOXYL SUBSTITUTED N-(1-AZABICYCLO[2.2.2]OCT-3-YL)-5-CHLOROBENZAMIDESAS POTENTIAL RADIOLIGANDS

      Nuclear medicine and biology
    2. HEWLETT WA; FRIDMAN S; TRIVEDI BL; SCHMIDT DE; DEPAULIS T; EBERT MH
      CHARACTERIZATION OF DESAMINO-5-[I-125]IODO-3-METHOXYZACOPRIDE ([I-125]MIZAC) BINDING TO 5-HT3 RECEPTORS IN THE RAT-BRAIN

      Progress in neuro-psychopharmacology & biological psychiatry
    3. DEPAULIS T; HEWLETT WA; SCHMIDT DE; MASON NS; TRIVEDI BL; EBERT MH
      SYNTHESIS AND 5-HT-3 RECEPTOR-BINDING ACTIVITY OF DIMETHOXY-N-(1-AZABICYCLO[2.2.2]OCT-3-YL)BENZAMIDE AND ITS 5-HALOGEN-2-ALKOXYL HOMOLOGS

      European journal of medicinal chemistry
    4. HEWLETT WA; DEPAULIS T; MASON NS; SCHMIDT DE; TRIVEDI BL; ZHANG ZJ; EBERT MH
      SYNTHESIS AND RADIOLABELING OF -METHOXY-N-(1-AZABICYCLO[2.2.2]OCT-3-YL)BENZAMIDE, THE ACTIVE ENANTIOMER OF [I-125] IODOZACOPRIDE, AND REEVALUATION OF ITS 5-HT3 RECEPTOR AFFINITY

      Chemical and Pharmaceutical Bulletin
    5. DEPAULIS T; TRIVEDI BL; ZHANG ZJ; SCHMIDT DE; EBERT MH; HEWLETT WA
      2-METHOXY-N-(1-AZABICYCLO[2.2.2]OCT-3-YL)BENZAMIDE (TRIZAC), A HIGH-AFFINITY LIGAND FOR THE 5-HT-3 RECEPTOR

      Bioorganic & medicinal chemistry letters
    6. MASON NS; HEWLETT WA; EBERT MH; SCHMIDT DE; DEPAULIS T
      LABELING OF (S)-DES-4-AMINO-3-[I-125]IODOZACOPRIDE (DAIZAC), A HIGH-AFFINITY RADIOLIGAND FOR THE 5-HT-3 RECEPTOR

      Journal of labelled compounds & radiopharmaceuticals
    7. VOTAW JR; ANSARI MS; MASON NS; SCHMIDT D; DEPAULIS T; HOLBURN G; CLANTON JA; VOTAW DB; MANNING RG; KESSLER RM
      DOSIMETRY OF IODINE-123-EPIDEPRIDE - A DOPAMINE D2 RECEPTOR-LIGAND

      The Journal of nuclear medicine
    8. PHILLIPS ST; DEPAULIS T; NEERGAARD JR; BARON BM; SIEGEL BW; SEEMAN P; VANTOL HHM; GUAN HC; SMITH HE
      BINDING OF 5H-DIBENZO[A,D]CYCLOHEPTENE AND DIBENZ[B,F]OXEPIN ANALOGS OF CLOZAPINE TO DOPAMINE AND SEROTONIN RECEPTORS

      Journal of medicinal chemistry
    9. HEWLETT WA; DEPAULIS T; SCHMIDT DE; TRIVEDI BL; MASON NS; EBERT MH
      I-125 LIZAC, A NOVEL LIGAND-BINDING WITH HIGH-AFFINITY TO 5-HT-3 CNS RECEPTORS

      Biological psychiatry
    10. KESSLER RM; MASON NS; ANSARI MS; DEPAULIS T; CLANTON JA; MANNING RG; HOLBURN G; FORRESTER JW
      N-ALLYL EPIDEPRIDE - AN EXTREMELY POTENT SPECT RADIOLIGAND FOR THE DOPAMINE D2 RECEPTOR

      The Journal of nuclear medicine
    11. SCHMIDT DE; VOTAW JR; KESSLER RM; DEPAULIS T
      AROMATIC AND AMINE SUBSTITUENT EFFECTS ON THE APPARENT LIPOPHILICITIES OF N-[(2-PYRROLIDINYL)METHYL]-SUBSTITUTED BENZAMIDES

      Journal of pharmaceutical sciences
    12. PHILLIPS ST; DEPAULIS T; BARON BM; SIEGEL BW; SEEMAN P; VANTOL HHM; GUAN HC; SMITH HE
      BINDING OF 5H-DIBENZO[B,E][1,4]DIAZEPINE AND CHIRAL 5H-DIBENZO[A,D]CYCLOHEPTENE ANALOGS OF CLOZAPINE TO DOPAMINE AND SEROTONIN RECEPTORS

      Journal of medicinal chemistry
    13. KESSLER RM; VOTAW JR; DEPAULIS T; BINGHAM DR; ANSARI MS; MASON NS; HOLBURN G; SCHMIDT DE; VOTAW DB; MANNING RG; EBERT MH
      EVALUATION OF 5-[F-18]FLUOROPROPYLEPIDEPRIDE AS A POTENTIAL PET RADIOLIGAND FOR IMAGING DOPAMINE D2 RECEPTORS

      Synapse
    14. VOTAW JR; KESSLER RM; DEPAULIS T
      FAILURE OF THE 3-COMPARTMENT MODEL TO DESCRIBE THE PHARMACOKINETICS IN BRAIN OF A HIGH-AFFINITY SUBSTITUTED BENZAMIDE

      Synapse
    15. KESSLER RM; MASON NS; VOTAW JR; ANSARI MS; DEPAULIS T; SCHMIDT DE; MANNING RG
      FACTORS UNDERLYING THE D-AMPHETAMINE INDUCED DISPLACEMENT OF DOPAMINED2 RADIOLIGANDS IN RHESUS-MONKEYS

      The Journal of nuclear medicine
    16. VOTAW JR; KESSLER RM; DEPAULIS T; ANSARI MS; MASON NS; SCHMIDT DE; MANNING RG; HOLBURN G
      QUANTIFICATION OF STRIATAL AND EXTRASTRIATAL DOPAMINE D2 RECEPTORS USING N-ALLYL-[18F]FPE

      The Journal of nuclear medicine
    17. VOTAW JR; KESSLER RM; ANSARI MS; MASON NS; SCHMIDT D; VOTAW DB; BELL RL; MINNICK DK; DEPAULIS T; MANNING RM; HOLBURN G
      DOSIMETRY OF I-123 EPIDERPRIDE

      The Journal of nuclear medicine
    18. KESSLER RM; DEPAULIS T; ANSARI MS; VOTAW JR; SCHMIDT DE; MANNING RG
      N-ALLYL-5-FLUOROPROPYLEPIDEPRIDE - A VERY POTENT AND SPECIFIC DOPAMINE-D2 PET RADIOLIGAND

      The Journal of nuclear medicine
    19. KESSLER RM; VOTAW JR; SCHMIDT DE; ANSARI MS; HOLDEMAN KP; DEPAULIS T; CLANTON JA; PFEFFER R; MANNING RG; EBERT MH
      HIGH-AFFINITY DOPAMINE D2 RECEPTOR RADIOLIGANDS .3. [I-123] AND [I-125] EPIDEPRIDE - INVIVO STUDIES IN RHESUS-MONKEY BRAIN AND COMPARISON WITH INVITRO PHARMACOKINETICS IN RAT-BRAIN

      Life sciences
    20. KESSLER RM; WHETSELL WO; ANSARI MS; VOTAW JR; DEPAULIS T; CLANTON JA; SCHMIDT DE; MASON NS; MANNING RG
      IDENTIFICATION OF EXTRASTRIATAL DOPAMINE D2 RECEPTORS IN POSTMORTEM HUMAN BRAIN WITH [I-125] EPIDEPRIDE

      Brain research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:15:45